Murine models for human diseases;Modelos murinos de enfermedades humanas

Medicina

Volumn 61, Issue 2, 2001, Pages 215-231

  Benavides, Fernando ^a   Guenet, Jean Louis ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b INSTITUT PASTEUR   (France)

Author keywords

Animal models; Genetic diseases; Laboratory mouse

Indexed keywords

ANIMAL; DISEASE MODEL; EXPERIMENTAL ANIMAL; GENETIC DISORDER; GENETICS; GENOME; HUMAN; MOUSE; MUTATION; RAT; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, LABORATORY; DISEASE MODELS, ANIMAL; GENETIC DISEASES, INBORN; GENOME, HUMAN; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; RATS;

EID: 0035231342     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Benavides F, Guénet JL. Mapeo de genes en el ratón. Medicina (Buenos Aires) 1997; 57: 507-10.
2. Bedell, M.A., Jenkins, N.A., Copeland, N.G. Mouse models of human disease. Part I: Techniques and resources for genetic analysis in mice. Genes & amp; Development 1997; 11: 1-10.
3. Bedell, M.A., Largaespada, D.A., Jenkins, N.A., et al. Mouse models of human disease. Part II: Recent progress and future directions. Genes & amp; Development 1997; 11: 11-43.
4. Borelli, E.R., Heyman, R., Hsi, M., et al. Targeting of an inducible toxic phenotype in animal cells, Proc Natl Aced Sci USA 1988; 85: 7572-6.
5. Bernstein, A. and Breitman, M.L. Genetic ablation in transgenic mice, Molecular Biology and Medecine 1989; 6: 523-30.
6. Jackson y Abbott. Mouse Genetics and Transgenics. A practical approach. Oxford: Oxford University Press; 2000.
7. Cory, S. and Adams, J. M. Transgenic mice and oncogenesis. Ann Rev Immunol 1988; 6: 25-48.
8. Heisterkamp N, Jenster G, ten Hoeve J, et al. Acute leukemia in bcr/abl transgenic mice. Nature 1990; 344: 251-3.
9. Koike S, Taya C, Kurata T, et al. Transgenic mice susceptible to pollovirus. Proc Natl Acad Sci USA 1991; 88: 951-5.
10. Lee, J.T. and Jaenisch, R. A method for high efficiency YAC lipo-fection into murine embryonic stem cells. Nucleic Acids Research 1996; 24: 5054-5.
11. Umland T, Montoliu L, Schütz G. The use of yeast artificial chromosomes for transgenesis. In: Houdebine, L.M. (ed). Transgenic animals: generation and use. Harwood Press, 1997, p 289-98.
12. Huxley C, Passage E, Manson A, et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996; 5: 563-9.
13. Rahmani Z, Blouin J, Creau-Goldberg N, et al. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci USA 1989; 86: 5958-62.
14. Smith DJ, Zhu Y, Zhang J, et al. Construction of a panel of transgenic mice containing a contiguous 2Mb set of YAC/P1 clones from human chromosome 21-q22.2. Genomics 1995; 27: 425-34.
15. Smith DJ, Stevens ME, Sudanagunta S, et al. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates mini-brain in learning defects associated with Down syndome. Nature Genet 1997; 16: 28-36.
16. Barnes GT, Duyao MP, Ambrose CM, et al. Mouse Huntington's disease gene homolog (Hdh). Somat Cell Mol Genet 1994; 20: 87-97.
17. Paigen, K. A miracle enough: the power of mice. Nature Medicine 1995; 1: 215-20.
18. Guénet, J.-L. Animal models of human genetic diseases. In: Vega MA (ed). Gene Targeting. CRC Press, 1995, p 149-166.
19. Smithies O. Animal models of human genetic diseases. Trends Genet 1993; 9: 112-6.
20. Sundberg JP. Handbook of mouse mutations with skin and hair abnormalities. Boca Raton: CRC Press, 1994.
21. Hosoda K, Hammer RE, Richardson JA, et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994; 79: 1267-76.
22. Fleischman RA. From white spots to stem cells: the role of the Kit receptor in mammalian development. Trends Genet 1993; 9: 285-90.
23. Tassabehji M, Newton VE, Liu XZ, et al. The mutational spectrum in Waardenburg syndrome. Hum Mol Genet 1995; 4: 2131-7.
24. Jackson IJ, Raymond S. Manifestations of microphthalmia. Nat Genet 1994; 8: 209-10.
25. Hanson I, van Heyningen V. Pax6: more than meets the eye. Trends Genet 1995; 11: 268-72.
26. McInnes RR, Bascom RA. Retinal genetics: a nullifying effect for rhodopsin. Nat Gene 1992; 1: 155-7.
27. Gibson F, Walsh J, Mburu P, et al. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995; 374: 62-4.
28. Dolle P, Dierich A, LeMeur M, et al. Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 1993; 75: 431-41.
29. Muenke M, Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 1995; 11: 308-13.
30. Stacey AJ, Bateman T, Choi T, et al. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant proa1 (I) collagen gene. Nature 1988; 332: 131-6.
31. Pericak-Vance MA, Haines JL. Genetic susceptibility to Alzheimer disease. Trends Genet 1995; 11: 504-8.
32. Sicinskl P, Geng Y, Ryder-Cook AS, et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989; 244: 1578-80.
33. Cox GA, Sunada Y, Campbell KP, et al. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet 1994; 8: 333-9.
34. Megeney LA, Kablar B, Garrett K, et al. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996; 10: 1173-83.
35. Jansen G, Groenen PJ, Bachner D, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 1996; 13: 316-24.
36. Doolittle, D., Davisson, M., Guidi, J, et al. Catalog of mutant genes and polymorphic loci. In: Lyon M, Rastan S, Brown S (eds). Genetic Variants and Strains of the Laboratory Mouse. Oxford: Oxford University Press, 1996, p 17-854.
37. Sundberg JP, Schultz LD. Inherited mouse mutations: models for the study of alopecia. J Invest Dermatol 1991; 96: 95S-6S.
38. Ahmad W, Faiyaz ul Haque M, Brancolini V, et al. Alopecia universalis associated with a mutation in the human hairless gene. Science 1998; 279: 720-4.
39. Benavides F, Giordano M, Fiette L, et al. Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency. Immunogenetics 1999; 49: 413-9.
40. Ryan TH, Townss TM, Reilly MP, et al. Human sickle hemoglobin in transgenic mice. Science 1990; 247: 566-7.
41. Fabry ME. Transgenic animal models of sickle cell disease. Experientia 1993; 49:28-36.
42. Barbosa MD, Nguyen QA, Tchernev VT, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Mature 1996; 362: 262-5.
43. Schorpp M, Hofman M, Dear TN, et al, Characterization of mouse and human nude genes. Immunogenetics 1997; 46: 509-15.
44. Hendrickson EA. The SCID mouse: relevance as an animal model system for studying human disease. Am J Pathol 1993; 143: 1511-22.
45. Jhappan C, Morse HC 3rd, Fleischmann RD, et al. DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat Genet 1997; 17: 483-6.
46. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935-46.
47. Kuehn, M.R., Bradley, A., Robertson, E.J., et al. A potential animal model for Lesch-Nyhan Sindrome through introduction of HPRT mutations into mice. Nature 1987; 326: 295-8.
48. Rossiter BJ, Caskey CT. Hypoxantine-guanine phosphoribosyltransferase deficiency. Lesch-Nyhan sindrome and gout. In: Scriver CR, Beaudet AL, Sly WS, and Valle D. (eds). The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995, p 1679-7-06.
49. Drumm ML, Collins FS. Molecular biology of cystic fibrosis. Mol Genet Med 1993; 3: 33-68.
50. van Doorninck JH, French PJ, Verbeek E, et al. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J 1995; 14: 4403-11.
51. Goldstein MR. Lipoprotein(a): friend or foe? Am J Cardiol 1995; 75: 319.
52. Knecht TP, Glass CK. The influence of molecular biology on our understanding of lipoprotein metabolism and the pathobiology of atherosclerosis. Adv Genet 1995; 32: 141-98.
53. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533-8.
54. Nerenberg M, Hinrichs SH, Reynolds RK, et al. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987; 237: 1324-9.
55. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
56. Baker SM, Plug AW, Prolla TA, et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet 1998; 13: 336-42.
57. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75: 631-9.
58. Jacks T. Lossons from the p53 mutant mouse. J Cancer Res Clin Oncol 1996; 122: 319-27.
59. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 1996; 104: 293-300.
60. Wong FS, Janeway CA Jr. Insulin-dependent diabetes mellitus and its animal models. Curr Opin Immunol. 1999; 11: 643-7.
61. Erickson, R. P. Why isn't a mouse more like a man? Trends in Genetics 1989; 5: 13.
62. Erickson, R P. Mouse models of human genetic disease: which mouse is more like a man? Bio-Essays 1996; 18: 993.
63. Brandon, E.P., Idzerda, R.L., McKnight, G.S. Targeting the mouse genome : a compendium of KOs (part 1). Current Biology 1995; 5: 758-65.
64. Brandon, E. P., Idzerda, R.L., McKnight, G. S. Targeting the mouse genome : a compendium of KOs (part 2). Current Biology 1995; 5: 625-34.
65. Nolan PM, Peters J, Strivens M, et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 2000; 25: 440-3.